| | Patient baseline characteristics | CS group | DS group | P-Value |
| | Age, years | 61.4 | 62.2 | NS | | ≤60yr, % | 43.2 | 46.0 | NS | | >60yr, % | 56.8 | 54.0 | NS | | Female, % | 20.9 | 19.3 | NS | | BMI, kg/m2 | 25.5 | 25.4 | NS | | Current smoking, % | 51.9 | 51.3 | NS | | Diabetes mellitus, % | 38.1 | 39.2 | NS | | Hypertension, % | 67.9 | 68.5 | NS | | Dyslipidemia, % | 69.1 | 64.0 | NS | | Acute coronary syndrome, % | 71.7 | 67.5 | NS | | Left main disease, % | 37.8 | 38.9 | NS | | Triple vessel disease, % | 86.0 | 87.3 | NS | | Previous MI, % | 34.5 | 33.6 | NS | | Stroke or TIA, % | 10.6 | 12.6 | NS | | LVEF, % | 60.1 | 60.4 | NS | | LDL-C, mg/dL | 95.98 | 98.30 | NS | | TC, mmol/L | 4.33 | 4.33 | NS | | Creatinine, mg/dL | 0.939 | 0.937 | NS | | GFR, mL/min/1.73m2 | 83.25 | 83.76 | NS | | ALT, U/L | 31.44 | 31.19 | NS | | AST, U/L | 22.54 | 22.27 | NS | | Medication | | | | | Aspirin, % | 69.2 | 73.3 | NS | | Beta-blocker, % | 86.7 | 87.6 | NS | | ACEI or ARB, % | 39.1 | 39.3 | NS |
|
|